Biomotion Sciences Ordinary Shares

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$2.32
Previous Close
$2.23
Day Range
$2.32-$2.32
52W Range
$2.13-$63.45
Market Cap
$6.9M
Shares Short
145,745

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
$349.09

News

See more

Yahoo Finance • 5 hours ago

Silexion Therapeutics Successfully Completes Toxicology Studies for SIL204, Next-Generation RNA Silencing Therapy, Ahead of Phase 2/3 Clinical Trial in Pancreatic Cancer

Yahoo Finance • 13 days ago

Silexion Therapeutics GAAP EPS of -$2.88

Yahoo Finance • 13 days ago

Silexion Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Yahoo Finance • 2 months ago

Silexion Therapeutics Announces Positive New Human Cell Line Data Confirming Pan-KRAS Activity of SIL204, Demonstrating Up to 99.7% Inhibition and First Evidence in Gastric Cancer

About

CEO
Mr. Ilan Hadar M.B.A.
CFO
Ms. Mirit Horenshtein Hadar
Address
The Goldyne Savad Inst. of Gene Therapy, Jerusalem, Israel, 9112001
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
11